Year |
Citation |
Score |
2008 |
Bough K. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia. 49: 91-3. PMID 19049599 DOI: 10.1111/j.1528-1167.2008.01846.x |
0.468 |
|
2007 |
Bough KJ, Paquet M, Paré JF, Hassel B, Smith Y, Hall RA, Dingledine R. Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Research. 74: 232-6. PMID 17416486 DOI: 10.1016/j.eplepsyres.2007.03.002 |
0.559 |
|
2007 |
Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 48: 43-58. PMID 17241207 DOI: 10.1111/j.1528-1167.2007.00915.x |
0.386 |
|
2006 |
Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology. 60: 223-35. PMID 16807920 DOI: 10.1002/Ana.20899 |
0.457 |
|
2004 |
Doherty JJ, Alagarsamy S, Bough KJ, Conn PJ, Dingledine R, Mott DD. Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrus. The Journal of Physiology. 561: 395-401. PMID 15513941 DOI: 10.1113/jphysiol.2004.074930 |
0.564 |
|
2004 |
Bough KJ, Mott DD, Dingledine RJ. Medial perforant path inhibition mediated by mGluR7 is reduced after status epilepticus. Journal of Neurophysiology. 92: 1549-57. PMID 15152022 DOI: 10.1152/jn.00315.2004 |
0.593 |
|
2003 |
Bough KJ, Schwartzkroin PA, Rho JM. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia. 44: 752-60. PMID 12790887 DOI: 10.1046/J.1528-1157.2003.55502.X |
0.323 |
|
2002 |
Bough KJ, Gudi K, Han FT, Rathod AH, Eagles DA. An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Research. 50: 313-25. PMID 12200222 DOI: 10.1016/S0920-1211(02)00086-4 |
0.323 |
|
2000 |
Bough KJ, Yao SG, Eagles DA. Higher ketogenic diet ratios confer protection from seizures without neurotoxicity. Epilepsy Research. 38: 15-25. PMID 10604602 DOI: 10.1016/S0920-1211(99)00077-7 |
0.302 |
|
Low-probability matches (unlikely to be authored by this person) |
1999 |
Bough KJ, Valiyil R, Han FT, Eagles DA. Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet. Epilepsy Research. 35: 21-8. PMID 10232791 DOI: 10.1016/S0920-1211(98)00125-9 |
0.291 |
|
2001 |
Bough KJ, Eagles DA. Re: Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsy Research. 44: 213-7. PMID 11417499 DOI: 10.1016/S0920-1211(01)00189-9 |
0.289 |
|
1999 |
Bough KJ, Eagles DA. A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia. 40: 138-43. PMID 9952258 DOI: 10.1111/j.1528-1157.1999.tb02066.x |
0.276 |
|
1999 |
Bough KJ, Chen RS, Eagles DA. Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutyrate, elevates seizure threshold in the Rat. Developmental Neuroscience. 21: 400-6. PMID 10575264 |
0.265 |
|
2000 |
Bough KJ, Matthews PJ, Eagles DA. A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion. Epilepsy Research. 38: 105-14. PMID 10642038 DOI: 10.1016/S0920-1211(99)00079-0 |
0.251 |
|
2003 |
Stafstrom CE, Bough KJ. The ketogenic diet for the treatment of epilepsy : A challenge for nutritional neuroscientists Nutritional Neuroscience. 6: 67-79. PMID 12722982 DOI: 10.1080/1028415031000084427 |
0.209 |
|
2001 |
Bough KJ, Eagles DA. Comparison of the anticonvulsant efficacies and neurotoxic effects of valproic acid, phenytoin, and the ketogenic diet. Epilepsia. 42: 1345-53. PMID 11737171 DOI: 10.1046/j.1528-1157.2001.08901.x |
0.157 |
|
2019 |
Yeung DT, Bough KJ, Harper JR, Platoff GE. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology. PMID 31853736 DOI: 10.1007/s13181-019-00750-x |
0.102 |
|
2013 |
Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. Biomarkers for smoking cessation. Clinical Pharmacology and Therapeutics. 93: 526-38. PMID 23588313 DOI: 10.1038/Clpt.2013.57 |
0.045 |
|
2014 |
Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, Sharma J, Dougherty AH, Moeller FG. Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 202-19. PMID 23979119 DOI: 10.1038/Npp.2013.210 |
0.026 |
|
2018 |
Bough KJ, Pollock JD. Defining Substance Use Disorders: The Need for Peripheral Biomarkers. Trends in Molecular Medicine. PMID 29396146 DOI: 10.1016/j.molmed.2017.12.009 |
0.024 |
|
2015 |
Bough KJ, Rapaka R, White DA, Rutter J. Early career award in chemistry of drug abuse and addiction Drug and Alcohol Dependence. 156: e25-e26. DOI: 10.1016/j.drugalcdep.2015.07.987 |
0.01 |
|
Hide low-probability matches. |